Exar Corporation: Buyout Candidate At $16-Plus, With A Margin Of Safety [View article]
Excellent informative article - EXAR just announced another restructuring while maintaining its revenue forecast. Stock price looks extended but I'm reminded of IMOS which has never really pulled back for those who were waiting for a a better entry point.
2 Biotech Stocks On Sale [View article]
http://bit.ly/ISPtNK
Exar Corporation: Buyout Candidate At $16-Plus, With A Margin Of Safety [View article]